Choosing a Supplement Format: A Brand Owner's Decision Framework

Brand owners often open a first conversation with a manufacturer already holding a format in mind — "we want a gummy" or "we're thinking sachets" — before naming the customer the product is for. That instinct is understandable: format feels like the concrete, decidable part of a launch, while audience and positioning can feel abstract. But the format is downstream of commercial choices that have nothing to do with manufacturing capability. Who buys the product, where they buy it, how often they use it and how much launch budget is available to commit to a first production run all shape which format actually earns its place in the range, long before questions of matrix, texture or packaging come into play.

This matters because the formats a brand can choose between differ commercially as much as they differ physically. Some formats open a private-label entry point with a smaller first commitment; others start further up the development ladder because the format itself is more bespoke to build. Treating every format as an equally available option and picking on taste alone skips the step that actually determines cost, timeline, and how much of the brief needs development work before a first unit ships.

What follows works through that decision in the order a brand owner should actually make it: audience and ritual first, channel second, cost and route third, then a closer look at where gummies, sachets, oral strips, functional jellies and capsules each earn their place, and where they don't.

Every format reads differently depending on the moment a customer reaches for it. A gummy suits a daily-use ritual that wants to feel approachable rather than clinical — a multivitamin taken alongside breakfast, a beauty stack folded into an evening routine. A sachet suits a mix-in or pour-and-go moment: a greens blend stirred into water, an electrolyte serve mixed before a workout. An oral strip suits a moment that specifically rules out water and privacy — a focus dose before a meeting, a discreet dose taken in transit. None of these are format facts so much as ritual facts, and the ritual is what a brand owner actually knows about their customer before any manufacturing conversation starts.

The exercise worth doing before any brief is written is to describe the customer's moment in one sentence, then ask which format actually survives that description unchanged. A brand built around "the five minutes before a meeting" survives being served as a strip or a shot but reads awkwardly as a jar-based gummy that needs water and time. A brand built around "the evening wind-down ritual" survives as a gummy, a jelly or an oral liquid, but loses the ritual quality in a strip that dissolves in seconds. Writing the moment down first turns format choice into a test the format either passes or fails, instead of a preference argued after the fact.

This is also where a brand owner should be honest about which moment is genuinely central to the launch and which is aspirational. A range built for daily habit formation can justify the format complexity of a premium jelly or a filled gummy; a range built for trial and reach is usually better served starting on a format that keeps the first production run simple, then adding complexity once the core range is selling.

Channel changes what a format needs to do beyond the moment it serves. A DTC subscription brand can lean on a doypack or a sachet multipack because the unboxing experience and the resealable format support a repeat-purchase cadence; a retail listing depends more on shelf legibility, a familiar nutrition-table format and packaging that survives handling across a wider distribution chain than a single warehouse. A travel-and-trial SKU — a sample pack sold alongside a hero range, or a sachet handed out at point of sale — has different packaging and format priorities again: portability and a low per-unit footprint matter more than a premium unboxing moment.

Oral strips are a useful test case for channel-first thinking. A strip is a genuinely difficult fit for a retail shelf that competes on a nutrition-table read and a familiar silhouette, because a wallet or booklet format doesn't communicate "supplement" the way a bottle does at a glance. The same strip is a strong fit for a DTC or travel-first channel where the buyer already understands the format from the brand's own marketing and doesn't need shelf context to explain it. The lesson isn't that strips are a weak format — it's that the channel decides whether the format's core benefit, discretion and portability, is actually being paid for by the customer buying through that channel.

Functional jellies sit at a similar channel intersection: the sachet-format pouch reads DTC-first and travel-friendly, but the premium, dual-sensory story that justifies a jelly's added production complexity is harder to communicate through a retail listing than through a brand's own product photography and copy. A brand choosing a jelly for retail distribution should expect to do more channel-side work to earn back that complexity than a brand launching the same format direct-to-consumer.

Brand owners often frame the format decision around unit cost, but the more consequential number is which commercial route a format enters through, because that decides the first production commitment and how much of the brief is genuinely bespoke before a unit ships. DAT Supply's commercial model runs three routes. The Ready private-label option carries an existing catalogue formulation onto a brand's own artwork, with the formula unchanged. Make it Yours keeps the same base formula but adjusts flavour, colour or shape within an approved set — naming and label artwork still follow the standard private-label branding process, not a separate design track. Custom Formula R&D starts from the brief rather than an existing formula and is scoped as its own development package.

The Ready private-label option starts from 1,000 units for a standard PET bottle, or 2,500 units where the packaging is a doypack. Make it Yours starts from 2,500 units, because a flavour, colour or shape change moves the batch outside the standard catalogue run. Custom Formula R&D volumes are confirmed after the development scope is agreed, rather than published as a fixed number, since the production quantity depends on what the new formulation actually requires. Lead time follows the same planning band across every route and format — from 5–12 weeks depending on format, packaging, production slot and destination market — with the confirmed timeline set during order setup, not before.

What changes by format is which rung of that ladder is available at all. Gummies and sachets are the two formats with a genuine Ready private-label entry point today: a brand can carry an existing catalogue concept onto its own artwork at the 1,000-unit tier without a formulation step in between. Oral strips, functional jellies and capsules don't currently offer that entry point — every project in those formats starts as Make it Yours or Custom Formula R&D, because the matrix, active-film compatibility or shell-and-fill spec is bespoke enough that a true drop-in private-label run isn't the default. That single fact, not a general sense of which format is harder to build, is what should point a first-launch brand toward gummies or sachets and leave a format like jellies or strips for a second SKU once the range has proven itself.

Whichever format and route apply, claims, on-pack labelling and market compliance remain the brand owner's responsibility across every route; DAT Supply's part is releasing the documentation set — specification, allergen statement and the batch Certificate of Analysis — that supports that review, by order stage. That division of responsibility doesn't change format to format, so it belongs in the decision only as a constant, not as a variable to weigh against audience, channel or cost.

Gummies earn their position as the default first-SKU format for a specific commercial reason: they are one of only two formats with a Ready private-label entry point, so a brand can reach a sellable first run without a formulation step and without the extra development budget that Make it Yours or Custom Formula R&D require. The format also reads broadly across daily wellness, beauty and sleep positioning without needing the brand to explain the format itself — a customer already knows what a gummy is and how to take it, which removes an education step from the brand's own marketing.

The trade-off is payload. Gummies carry water-soluble vitamins, minerals in well-tolerated salt forms, botanical extracts at extractive ratios that survive the cook, and selected amino acids well, but a multi-piece serving paces the dose rather than concentrating it into a single unit — a format decision, not a formulation limit, since the same active stack in a capsule or sachet can carry a different serving structure. A brand whose positioning depends on a single-piece, concentrated serve is choosing against the format's core trade-off, not working with it.

The default stops applying once a brand has proven a gummy SKU and wants a second format that differentiates rather than duplicates. At that point the decision moves from "which format reaches a sellable first run with the least friction" to "which format earns a different customer moment" — the audience-and-ritual question introduced earlier, now applied to a second or third SKU rather than the first.

Sachets are the other format with a Ready private-label entry point, which makes the sachet-versus-gummy decision genuinely a ritual-and-channel question rather than a cost question — both routes start at the same 1,000-unit tier for a first run. The sachet format suits a mix-in or pour-and-go ritual that a gummy can't serve: a greens blend, an electrolyte serve, an instant drink concept, a collagen powder taken as a single-serve pour rather than chewed. Where a customer's moment is defined by "stirred into water" rather than "eaten," the sachet is the format that matches the ritual without adding development complexity.

Sachets also carry a channel advantage a gummy doesn't: the stick-pack sub-format works as a low-footprint trial or travel SKU alongside a hero range in another format, without the brand needing a second product concept. A brand selling a gummy multivitamin can add a sachet-format electrolyte or greens SKU as a range extension that reaches a different daily moment, using the same Ready private-label entry point rather than stepping up to Make it Yours for a genuinely new concept.

The format's constraint sits in fill compatibility rather than cost: not every active stack flows, dissolves or tastes acceptable as a powder, and a fill that works well as a capsule or gummy doesn't automatically translate. A brand considering a sachet SKU should treat fill behaviour — particle size, flow, dissolution, taste-masking — as the genuine feasibility question, rather than assuming the format choice is settled once the ritual fits.

Oral strips are the clearest case of a format that trades a larger first-production commitment for a specific customer benefit: because no strip currently ships through the Ready private-label route, every strip project starts as Make it Yours or Custom Formula R&D, at the 2,500-unit tier or above. That trade-off is worth making when discretion and no-water dosing are the actual reason a customer buys — a focus strip for a meeting, a sleep strip for a hotel room without a glass of water nearby, a breath strip that reads as a pocket item rather than a supplement.

The format also carries a real active-selection constraint that channel and ritual thinking alone won't surface: strip chemistry favours water-soluble, low-dose actives, and a stack built around a higher-strength or oil-based active is fighting the format rather than being served by it. A brand owner weighing a strip against a gummy or sachet for the same active stack should treat that active-compatibility question as a gate to clear before the commercial decision, not after — a strip that can't actually carry the target active isn't a lighter version of the same product, it's a different product.

Because strips start further up the route ladder, they suit a brand that has already proven a core range and wants a second SKU built around a genuinely different moment, rather than a first-launch format chosen to minimise upfront commitment. The commercial case for a strip is the customer benefit it unlocks, not the entry cost — the reverse of the case for gummies or sachets.

Functional jellies sit in a similar position to oral strips on the route ladder — no Ready private-label entry point, so every jelly project starts at Make it Yours or, more often, Custom Formula R&D, because fill chemistry, sachet hardware and outer presentation tend to be bespoke enough that a published jelly matrix rarely carries across brands unchanged. The commercial case for choosing a jelly over a gummy or a sachet rests on a specific positioning bet: a jelly reads as a more premium, more tactile daily ritual than either format, and that premium read is what has to justify the extra development step.

That makes jellies a stronger fit for a second or third SKU in an established range — a beauty collagen jelly sitting above a gummy multivitamin, an energy jelly extending a sachet-based range into a more indulgent moment — than for a first launch trying to reach a sellable run quickly. A brand that picks a jelly as its first SKU should go in expecting the development timeline and the Custom Formula R&D route from the outset, rather than discovering partway through the brief that the format doesn't have a shorter path.

The format's genuine strength is texture: a jelly reads as neither a candy nor a supplement in the way a gummy sometimes does, which gives a brand a sensory register a gummy or sachet can't easily reach. Whether that register is worth the extra route complexity depends entirely on whether the brand's positioning is built around that premium, tactile read — the same audience-and-ritual test introduced earlier, applied specifically to whether "premium" is actually the moment the customer is buying into.

Capsules don't currently carry a Ready private-label entry point either — like oral strips and functional jellies, a capsule project is reviewed per brief as Make it Yours or Custom Formula R&D rather than dropped in from an existing catalogue run. What capsules offer in exchange is a wide active-payload window and a clean, familiar nutrition-table presentation that reads clinical rather than confectionery — a genuine advantage for a range positioned around a broad or high-inclusion active stack that a gummy's cook process or a strip's film ceiling can't carry as cleanly.

This makes capsules a workhorse choice rather than a differentiating one: a brand rarely picks a capsule because the format itself carries brand story the way a jelly's texture or a strip's discretion does. It's picked because the active stack genuinely needs the payload window, or because the brand's positioning specifically wants to read as clinical rather than wellness-adjacent. A high-inclusion mineral stack, a broad multivitamin with a long active list, or a range that competes on ingredient transparency over sensory experience are the concepts that reach for a capsule first.

Because capsules sit at the same route tier as strips and jellies, the decision between them usually comes down to the audience-and-ritual test rather than cost: a capsule suits a customer who wants a clinical, no-frills daily habit; a jelly or gummy suits a customer who wants the format itself to feel like part of the brand experience. Weighing them side by side against the same brief is a quicker way to find the right answer than starting from format preference alone.

Pulled together, the decision runs in a consistent order regardless of which format a brand starts leaning toward. First, name the customer's moment in one sentence — daily habit, mix-in ritual, discreet dose, premium treat — and check which formats survive that description unchanged. Second, name the channel the launch actually depends on for its first meaningful volume — DTC subscription, retail shelf, travel-and-trial — because channel decides whether a format's core benefit is being paid for by the customer buying through it. Third, check which route-ladder rung the format sits on: gummies and sachets open at the Ready private-label tier; oral strips, functional jellies and capsules start at Make it Yours or Custom Formula R&D, which changes both the first-production commitment and how much of the brief needs genuine development work before a unit ships.

A first-launch brand with a tight runway and a still-unproven concept is almost always better served starting on gummies or sachets, because the format decision and the cost decision point the same direction — the format that fits a broad daily-use moment is also the format with the smaller entry commitment. A brand adding a second or third SKU to an already-selling range can afford to let the audience-and-ritual test outrank the cost test, because the core range is already de-risking the launch; that's the point at which a jelly, a strip or a capsule earns its place precisely because it reaches a moment the existing range doesn't.

The mistake to avoid in either direction is picking a format first and reverse-engineering the audience to fit it. A gummy chosen because it's the comfortable default for a concept that's actually built around a discreet, no-water moment is fighting its own positioning from day one; a jelly or strip chosen for a first launch without the runway to absorb a Make it Yours or Custom Formula R&D timeline creates a cost problem the brand didn't need to take on. Running the audience, channel and route questions in order, before the format conversation rather than during it, is what keeps the two decisions aligned instead of working against each other.

It's worth being explicit that format and packaging are two different decisions, even though they get discussed together often enough that brands sometimes conflate them. A gummy can ship in a PET bottle, a doypack or a sachet; a capsule can ship in a bottle, a blister or a doypack; the packaging choice changes the unboxing experience and the channel fit without changing the underlying format decision worked through above. A brand that has settled on gummies for the audience-and-ritual reasons above still has a genuine packaging decision ahead of it — bottle for a retail-first, nutrition-table-led SKU, doypack for a DTC subscription cadence, sachet for a travel or trial companion to a bottle-format hero SKU.

Keeping the two decisions separate matters because packaging is confirmed later in the process than format, and treating them as one decision tends to lock in a packaging choice before the channel question has actually been answered. The practical sequence is format first, settled against audience, channel and route, then packaging, confirmed once the channel and first-order volume are clear enough to make that call properly.

A format conversation goes faster and reaches a better answer when a brand owner arrives with the audience-and-ritual sentence already written, a channel already named, and an honest sense of which route tier the launch can actually absorb — Ready private-label, Make it Yours or Custom Formula R&D. None of that requires the brand to have picked a format yet; it requires having answered the questions a format choice actually depends on, so the conversation about gummies, sachets, oral strips, functional jellies or capsules starts from the brief rather than from a preference.

From there, the private-label catalogue and the individual format capability pages are the places to check what an existing concept in each format actually looks like before committing to a route. Where the brief doesn't map cleanly onto an existing concept — a genuinely new active combination, an unusual matrix requirement, a format pairing that isn't in the current catalogue — that's the signal to start the conversation as a Custom Formula R&D brief rather than trying to force it into an existing route.

Sending the brief with the audience, channel and route already thought through is what lets a first conversation confirm a working route and a documentation path quickly, rather than spending the first exchange establishing facts the brand owner already had the answer to before writing in.